Correlation between COX-2 expression and hormone receptors in invasive ductal breast cancer

Jung Ah Lee, Jeoung Won Bae, Sang- Uk Woo, Hyunchul Kim, Chul Hwan Kim

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

COX-2 is known to be elevated in breast cancer, but the clinical relevance is still a matter of debate. The purpose of this study was to determine the prognostic significance and relationship of COX-2 to hormone receptors. Between January 2005 and February 2007, 80 specimens from breast cancer patients at Korea University Anam Hospital were reviewed by one pathologist. COX-2 was analyzed as overexpressed if <10% of the cells were stained. Clinical characteristics, hormone receptor status, and other prognostic factors were investigated to determine their association with COX-2 expression. Results: COX-2 was overexpressed in 12 patients (15%). Two patients had locoregional recurrence, eight patients had systemic metastasis, and one patient died. There was no statistically significant correlation between COX-2 expression and age, size, nodal status, histological grade, hormone receptor status, and HER-2/neu positivity. Among tumors that had a positive expression of ER and PR, COX-2 expression was related to larger size (P-value 0.001 and 0.009, respectively) and nodal status (P-value 0.048 and 0.009, respectively). However, there was no statistically significant correlation with tumors that had negative ER or PR expression. This study suggests that in breast cancer, COX-2 expression has no relationship with clinicopathologic factors; however, a correlation was noted in size and nodal status for ER- and PR-positive tumors. Further prospective study with larger population to clarify the relationship between COX-2 expression and hormone receptor status is necessary.

Original languageEnglish
Pages (from-to)140-148
Number of pages9
JournalJournal of the Korean Surgical Society
Volume78
Issue number3
DOIs
Publication statusPublished - 2010 Mar 1

Fingerprint

Hormones
Breast Neoplasms
Neoplasms
Korea
Prospective Studies
Neoplasm Metastasis
Recurrence
Population

Keywords

  • Breast cancer
  • Cyclooxygenase 2
  • Estrogen receptor
  • Progesterone receptor

ASJC Scopus subject areas

  • Surgery

Cite this

Correlation between COX-2 expression and hormone receptors in invasive ductal breast cancer. / Lee, Jung Ah; Bae, Jeoung Won; Woo, Sang- Uk; Kim, Hyunchul; Kim, Chul Hwan.

In: Journal of the Korean Surgical Society, Vol. 78, No. 3, 01.03.2010, p. 140-148.

Research output: Contribution to journalArticle

@article{e64dd499da6542d19e4ecc12ddd051e2,
title = "Correlation between COX-2 expression and hormone receptors in invasive ductal breast cancer",
abstract = "COX-2 is known to be elevated in breast cancer, but the clinical relevance is still a matter of debate. The purpose of this study was to determine the prognostic significance and relationship of COX-2 to hormone receptors. Between January 2005 and February 2007, 80 specimens from breast cancer patients at Korea University Anam Hospital were reviewed by one pathologist. COX-2 was analyzed as overexpressed if <10{\%} of the cells were stained. Clinical characteristics, hormone receptor status, and other prognostic factors were investigated to determine their association with COX-2 expression. Results: COX-2 was overexpressed in 12 patients (15{\%}). Two patients had locoregional recurrence, eight patients had systemic metastasis, and one patient died. There was no statistically significant correlation between COX-2 expression and age, size, nodal status, histological grade, hormone receptor status, and HER-2/neu positivity. Among tumors that had a positive expression of ER and PR, COX-2 expression was related to larger size (P-value 0.001 and 0.009, respectively) and nodal status (P-value 0.048 and 0.009, respectively). However, there was no statistically significant correlation with tumors that had negative ER or PR expression. This study suggests that in breast cancer, COX-2 expression has no relationship with clinicopathologic factors; however, a correlation was noted in size and nodal status for ER- and PR-positive tumors. Further prospective study with larger population to clarify the relationship between COX-2 expression and hormone receptor status is necessary.",
keywords = "Breast cancer, Cyclooxygenase 2, Estrogen receptor, Progesterone receptor",
author = "Lee, {Jung Ah} and Bae, {Jeoung Won} and Woo, {Sang- Uk} and Hyunchul Kim and Kim, {Chul Hwan}",
year = "2010",
month = "3",
day = "1",
doi = "10.4174/jkss.2010.78.3.140",
language = "English",
volume = "78",
pages = "140--148",
journal = "Annals of Surgical Treatment and Research",
issn = "2288-6575",
publisher = "Korean Surgical Society",
number = "3",

}

TY - JOUR

T1 - Correlation between COX-2 expression and hormone receptors in invasive ductal breast cancer

AU - Lee, Jung Ah

AU - Bae, Jeoung Won

AU - Woo, Sang- Uk

AU - Kim, Hyunchul

AU - Kim, Chul Hwan

PY - 2010/3/1

Y1 - 2010/3/1

N2 - COX-2 is known to be elevated in breast cancer, but the clinical relevance is still a matter of debate. The purpose of this study was to determine the prognostic significance and relationship of COX-2 to hormone receptors. Between January 2005 and February 2007, 80 specimens from breast cancer patients at Korea University Anam Hospital were reviewed by one pathologist. COX-2 was analyzed as overexpressed if <10% of the cells were stained. Clinical characteristics, hormone receptor status, and other prognostic factors were investigated to determine their association with COX-2 expression. Results: COX-2 was overexpressed in 12 patients (15%). Two patients had locoregional recurrence, eight patients had systemic metastasis, and one patient died. There was no statistically significant correlation between COX-2 expression and age, size, nodal status, histological grade, hormone receptor status, and HER-2/neu positivity. Among tumors that had a positive expression of ER and PR, COX-2 expression was related to larger size (P-value 0.001 and 0.009, respectively) and nodal status (P-value 0.048 and 0.009, respectively). However, there was no statistically significant correlation with tumors that had negative ER or PR expression. This study suggests that in breast cancer, COX-2 expression has no relationship with clinicopathologic factors; however, a correlation was noted in size and nodal status for ER- and PR-positive tumors. Further prospective study with larger population to clarify the relationship between COX-2 expression and hormone receptor status is necessary.

AB - COX-2 is known to be elevated in breast cancer, but the clinical relevance is still a matter of debate. The purpose of this study was to determine the prognostic significance and relationship of COX-2 to hormone receptors. Between January 2005 and February 2007, 80 specimens from breast cancer patients at Korea University Anam Hospital were reviewed by one pathologist. COX-2 was analyzed as overexpressed if <10% of the cells were stained. Clinical characteristics, hormone receptor status, and other prognostic factors were investigated to determine their association with COX-2 expression. Results: COX-2 was overexpressed in 12 patients (15%). Two patients had locoregional recurrence, eight patients had systemic metastasis, and one patient died. There was no statistically significant correlation between COX-2 expression and age, size, nodal status, histological grade, hormone receptor status, and HER-2/neu positivity. Among tumors that had a positive expression of ER and PR, COX-2 expression was related to larger size (P-value 0.001 and 0.009, respectively) and nodal status (P-value 0.048 and 0.009, respectively). However, there was no statistically significant correlation with tumors that had negative ER or PR expression. This study suggests that in breast cancer, COX-2 expression has no relationship with clinicopathologic factors; however, a correlation was noted in size and nodal status for ER- and PR-positive tumors. Further prospective study with larger population to clarify the relationship between COX-2 expression and hormone receptor status is necessary.

KW - Breast cancer

KW - Cyclooxygenase 2

KW - Estrogen receptor

KW - Progesterone receptor

UR - http://www.scopus.com/inward/record.url?scp=79960187699&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960187699&partnerID=8YFLogxK

U2 - 10.4174/jkss.2010.78.3.140

DO - 10.4174/jkss.2010.78.3.140

M3 - Article

VL - 78

SP - 140

EP - 148

JO - Annals of Surgical Treatment and Research

JF - Annals of Surgical Treatment and Research

SN - 2288-6575

IS - 3

ER -